Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01752 |
| Species: | Homo sapiens |
| Position : | chr2:233768020-233768954 |
| Year: | 2025 |
| Title: | Drug-induced cis-regulatory elements in human hepatocytes affect molecular phenotypes associated with adverse reactions |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | hepatocellular carcinoma |
| PMID: | 40301309 |
| MONDO: | MONDO:0007256 |
| Tissue: | Liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | HepaRG cells |
| CVCL ID: | CVCL_5J53 |
| Cell Type: | hepatocellular carcinoma cell |
| Cell Ontology ID: | CL:0000182 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | CAGE |
| Low Throughput Method: | CRISPRi |
| Target gene : | UGT1A1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|